SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.17 CNY | -0.70% |
|
+2.11% | -3.44% |
| May. 10 | Fosun Pharma Unit Gets China Marketing Approval for Schizophrenia Tablets | MT |
| May. 09 | Shanghai Fosun Pharmaceutical Unit Secures China Nod to Sell Schizophrenia Drug | MT |
Chart calendar Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
fe15152.5gtw7uvpuaA7CAACS2tUjD1y8Z6-FlyKjxRw9NDu3OI.y0o4ipmLyvYPXUFDeDw--QgDxv3MdTrn1lNDpbrftYSkYDqso6_o6X9kUQ~9f4816ff7dfb2ae05a39af4f2b3ba7ff
Upcoming events on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Past events on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| 2024-04-28 | Q1 2024 Earnings Release |
| 2024-03-26 | Q4 2023 Earnings Call |
| 2024-03-26 09:29 am | Q4 2023 Earnings Release |
| 2023-10-29 | Q3 2023 Earnings Release |
| 2023-10-13 01:30 am | Extraordinary Shareholders Meeting |
| 2023-08-28 | Q2 2023 Earnings Release |
| 2023-08-08 | Ex-dividend day for final dividend |
| 2023-06-28 01:00 am | Annual General Meeting |
| 2023-06-05 | BIO International Convention |
| 2023-05-09 | BEYOND International Technology Innovation Expo |
| 2023-04-27 | Q1 2023 Earnings Release |
| 2023-03-27 | Q4 2022 Earnings Release |
| 2022-11-29 12:30 am | Extraordinary Shareholders Meeting |
| 2022-10-29 | Q3 2022 Earnings Release |
| 2022-09-07 | Interim 2022 Earnings Call |
| 2022-08-29 10:39 am | Interim 2022 Earnings Release |
| 2022-08-10 01:30 am | Extraordinary Shareholders Meeting |
| 2022-06-15 | Ex-dividend day for final dividend |
| 2022-06-01 01:00 am | Annual General Meeting |
| 2022-04-25 | Q1 2022 Earnings Release |
Past dividends on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| 2023-08-08 | Annual 0.42 CNY |
| 2022-06-15 | Annual 0.56 CNY |
| 2021-07-18 | Annual 0.43 CNY |
| 2020-07-29 | Annual 0.39 CNY |
| 2019-08-01 | Annual 0.32 CNY |
| 2018-08-02 | Annual 0.38 CNY |
| 2017-08-08 | Annual 0.35 CNY |
| 2016-06-22 | Annual 0.32 CNY |
| 2015-08-11 | Annual 0.28 CNY |
| 2014-08-18 | Annual 0.27 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 28 585 28 872 -0.99% | 30 307 32 997 -8.15% | 39 005 36 588 6.61% | 43 952 44 831 -1.96% | 41 400 41 589 -0.46% | 44 429 |
|
EBITDA Million CNY | Released Forecast Spread | 5 874 3 780 55.4% | 6 282 4 732 32.74% | 8 105 5 208 55.63% | 6 889 6 310 9.18% | 6 160 4 842 27.22% | 6 999 |
|
EBIT Million CNY | Released Forecast Spread | 4 494 2 613 71.95% | 4 721 3 879 21.72% | 6 314 3 230 95.46% | 4 657 4 284 8.69% | 3 308 1 915 72.68% | 3 649 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 4 526 4 527 -0.03% | 4 678 4 901 -4.55% | 6 054 5 866 3.21% | 4 574 5 099 -10.29% | 3 265 4 414 -26.04% | 4 328 |
|
Net income Million CNY | Released Forecast Spread | 3 322 3 337 -0.45% | 3 663 3 531 3.72% | 4 735 4 467 6% | 3 731 3 769 -1.01% | 2 386 3 373 -29.26% | 3 140 |
|
EPS CNY | Released Forecast Spread | 1,30 1,32 -1.22% | 1,43 1,40 2.43% | 1,85 1,74 6.04% | 1,43 1,52 -6.04% | 0,89 1,24 -28.41% | 1,18 |
| Announcement Date | 30/03/20 | 29/03/21 | 22/03/22 | 27/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 10 382 9 609 8.04% | 10 893 10 623 2.54% | 10 270 10 045 2.24% | 12 341 12 561 -1.75% | 10 871 10 535 3.19% | 10 445 11 338 -7.88% | 9 305 10 612 -12.32% | 10 699 9 734 9.92% | 10 157 10 691 -5% | 10 889 | 10 631 | 11 279 | 10 475 | |
|
EBIT Million CNY | Released Forecast Spread | 863 819 5.4% | 1 136 691 64.4% | 1 046 1 020 2.49% | 1 064 1 267 -15.98% | 1 427 1 105 29.15% | 1 255 926 35.58% | 660 927 -28.85% | -34,7 843 -104.12% | 1 021 655 56.02% | 364 | 868 | 456 | 706 | |
|
EPS CNY | Released Forecast Spread | 0,18 0,33 -45.45% | 0,42 0,43 -1.18% | 0,35 0,41 -13.58% | 0,48 0,38 28% | 0,37 0,38 -2.63% | 0,30 0,33 -7.69% | 0,19 0,39 -51.28% | 0,04 0,41 -90.12% | 0,23 0,27 -14.81% | 0,31 | 0,39 | 0,31 | 0,18 | 0,05 |
| Announcement Date | 26/04/22 | 29/08/22 | 30/10/22 | 27/03/23 | 28/04/23 | 29/08/23 | 30/10/23 | 26/03/24 | 29/04/24 | - | - | - | - | - |
More events
Past sector events for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| 2024-05-10 11:01 am | PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-10 06:50 am | ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-10 06:46 am | NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-09 | NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-09 | KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-09 | JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-09 | TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:02 pm | COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release |
| 2024-05-09 09:58 am | SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release |
| 2024-05-09 09:06 am | ABBOTT INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600196 Stock
- Calendar Shanghai Fosun Pharmaceutical (Group) Co., Ltd.